What is Hearing Diagnostics?
Hearing Diagnostics Limited specializes in innovative hearing screening technology. Their offerings are tailored for community healthcare providers, hearing aid retailers, and local communities. The company's flagship product, the Hearing Diagnostics Screener, provides accurate and cost-efficient hearing tests outside traditional hospital settings, emphasizing high sensitivity and specificity. Furthermore, their AUDIMETROID technology empowers untrained professionals to conduct reliable hearing assessments, thereby alleviating the workload on audiologists and enhancing access to essential care.
How much funding has Hearing Diagnostics raised?
Hearing Diagnostics has raised a total of $1.3M across 1 funding round:
Unspecified
$1.3M
Unspecified (2022): $1.3M with participation from Archangels and Scottish Enterprise
Key Investors in Hearing Diagnostics
Archangels
Archangels, Inc., established in 1983, offers comprehensive architectural services for residential, commercial, and institutional clients, known for thoughtful design and professional service.
Scottish Enterprise
Scottish Enterprise, founded in 1991, is a national economic development agency and a non-departmental public body of the Scottish Government, headquartered in Glasgow.
What's next for Hearing Diagnostics?
With this major enterprise-level funding, Hearing Diagnostics is poised for significant expansion. The strategic investment will likely fuel advancements in their screening technology, broaden market reach, and potentially support further research and development into audiology solutions. The company's focus on accessibility and efficiency in hearing loss detection suggests a trajectory aimed at becoming a dominant force in preventative audiological care, both domestically and internationally.
See full Hearing Diagnostics company page
